LGND

Ligand Pharmaceuticals Inc. is a biopharmaceutical company that develops and acquires technologies to enable other pharmaceutical companies to discover and develop medicines. The company operates a unique royalty-based business model, partnering with biotechnology and pharmaceutical companies by providing its proprietary technology platforms. Ligand's diverse portfolio includes programs in antibody technologies, peptide therapeutics, and small molecule drug development across multiple therapeutic areas.